tirzepatide patent expiration eli lilly US pharmaceutical giant Lilly's weight loss drug Mounjaro (tirzepatide) records Rs 80 crore in revenue in September, making it the second-most sold drug by value in India. The top-selling drug for China approves Eli Lilly's blockbuster

Managing Side Effects Beyond the Sting While the injection itself is the focus of this guide, it is also important to remember that GLP-1 medications can cause other localized reactions

Many women lose between 5% to 15% of their starting weight over six months to a year

Side effects and tolerability Both medications share similar gastrointestinal side effects, which are typical for all GLP-1 receptor agonists

A: GLP-1 medications are typically offered to people with a BMI over 30, or over 27 if you have weight-related conditions

The Bottom Line Elevate Health offers a legitimate pathway to GLP-1 weight loss medications for individuals who meet clinical criteria, are comfortable with telehealth-only care, and prefer compounded medications over brand-name products

It has also been named by Evaluate as one of the most anticipated drugs to be approved in 2022